<?xml version="1.0" encoding="UTF-8"?>
<p>Another double-blind, randomized placebo-controlled trial testing the effects of CQ in 13 chronically HIV-infected persons was conducted in Minnesota. The results showed that the administration of CQ during chronic HIV infection resulted in decreased immune activation, but no data regarding HIV status were reported [
 <xref rid="B43-microorganisms-08-00085" ref-type="bibr">43</xref>].
</p>
